Legal Information Sold in the USA under exclusive license from the University of California. Biochem/physiol Actions TPMPA is a hybrid of isoguvacine and 3-APMPA designed to retain affinity for GABAC receptors but not to interact with GABAA or GABAB receptors. Electrical assays show that TPMPA is a competitive antagonist of cloned human mu 1 GABAC receptors expressed in Xenopus laevis oocytes (Kb approx. 2 μM). TPMPA is >100-fold weaker as an inhibitor of rat brain GABAA receptors expressed in oocytes (Kb approx. 320 μM) and has only weak agonist activity on GABAB receptors assayed in rat hippocampal slices (EC50 approx. 500 μM). TPMPA may be used to investigate GABAC receptor function in the outer retina and in any other areas of the nervous system in which these types of receptor are present.
References
PubChem Literature
No Data Available
Click here to submit data
Bioactivity
PubChem BioAssay
Properties
Product Information
Purity
≥97% (NMR)
Physical Property
Solubility
H2O: soluble16 mg/mL
DMSO: insoluble
Apperance
white to off-white solid
Safety Information
German water hazard class
3
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter